The Dissolution Test Apparatus is a precision instrument designed to evaluate the dissolution rate of tablets and capsules in compliance with USP, IP, EP, and JP standards. It is ideal for pharmaceutical quality control and research laboratories to ensure consistent drug release performance.
1.Drug Release Studies
To determine the rate and extent of active pharmaceutical ingredient (API) release from solid dosage forms such as tablets, capsules, and pellets.
Ensures batch-to-batch consistency of oral solid dosage forms during production.
Verifies that finished products meet pharmacopeial dissolution specifications.
3. Formulation Development
Used during product development to optimize formulation and identify suitable excipients for desired drug release profiles.
4. Bioequivalence Testing
Helps establish in-vitro–in-vivo correlation (IVIVC) between laboratory results and actual biological performance of the drug.
5. Stability Studies
Assesses how dissolution characteristics change under various storage conditions to ensure product stability and shelf life.
6. Regulatory Compliance
Provides data required by regulatory bodies (FDA, EMA, CDSCO, etc.) for drug approval and post-approval testing.
7. Research and Development (R&D)
Supports academic and industrial research focused on controlled-release and sustained-release formulations.